HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Osteosarcoma D012516 50 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Occupational Diseases D009784 42 associated lipids
Lung Diseases D008171 37 associated lipids
Glomerulonephritis D005921 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Chu LC et al. Chronic intrathecal infusion of gabapentin prevents nerve ligation-induced pain in rats. 2011 Br J Anaesth pmid:21441243
Ribeiro PO et al. Apoptotic neurodegeneration and spatial memory are not affected by sedative and anaesthetics doses of ketamine/medetomidine combinations in adult mice. 2012 Br J Anaesth pmid:22362669
Li Y et al. Human uveal melanoma expresses NG2 immunoreactivity. 2003 Br J Ophthalmol pmid:12714409
Sjö LD et al. Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. 2006 Br J Ophthalmol pmid:16672329
Tulvatana W et al. Risk factors for conjunctival squamous cell neoplasia: a matched case-control study. 2003 Br J Ophthalmol pmid:12642297
Shimmura S et al. Microkeratome assisted deep lamellar keratoprosthesis. 2006 Br J Ophthalmol pmid:16597665
Thinda S et al. Polycarbonate membrane impression cytology: evidence for fluorescein staining in normal and dry eye corneas. 2010 Br J Ophthalmol pmid:20424211
Sawa M et al. Application of femtosecond ultrashort pulse laser to photodynamic therapy mediated by indocyanine green. 2004 Br J Ophthalmol pmid:15148220
Smith JR et al. Expression of vascular endothelial growth factor and its receptors in rosacea. 2007 Br J Ophthalmol pmid:17244661
Crosby MB et al. Serum vascular endothelial growth factor (VEGF) levels correlate with number and location of micrometastases in a murine model of uveal melanoma. 2011 Br J Ophthalmol pmid:20819828
Schnurrbusch UE et al. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. 2001 Br J Ophthalmol pmid:11520762
Delarive T et al. Aqueous dynamic and histological findings after deep sclerectomy with collagen implant in an animal model. 2003 Br J Ophthalmol pmid:14609829
Marback EF et al. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma. 2003 Br J Ophthalmol pmid:14507753
Dua HS et al. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. 2005 Br J Ophthalmol pmid:15834076
Sheidow TG et al. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. 2000 Br J Ophthalmol pmid:10873988
Touhami A et al. Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia. 2005 Br J Ophthalmol pmid:15722301
Shimmura S et al. Transplantation of corneal endothelium with Descemet's membrane using a hyroxyethyl methacrylate polymer as a carrier. 2005 Br J Ophthalmol pmid:15665339
Kim SG et al. Histological changes in the temporomandibular joint in rabbits depending on the extent of mandibular lengthening by osteodistraction. 2004 Br J Oral Maxillofac Surg pmid:15544889
Varley I et al. Pinning out pathological specimens--are we risking an unnecessary escalation of treatment? 2015 Br J Oral Maxillofac Surg pmid:25799957
Umeda M et al. Experimental model of invasion and metastasis by orthotopic transplantation of oral squamous and adenoid cystic carcinomas into the tongue of nude mice. 2001 Br J Oral Maxillofac Surg pmid:11601820
Ma Y and Shen G Distraction osteogenesis after irradiation in rabbit mandibles. 2012 Br J Oral Maxillofac Surg pmid:22079566
Topping A et al. Successful reduction in skin damage resulting from exposure to the normal-mode ruby laser in an animal model. 2001 Br J Plast Surg pmid:11207126
Nayak BB et al. A microneurovascular study of the great saphenous vein in man and the possible implications for survival of venous flaps. 2000 Br J Plast Surg pmid:10738330
Leslie TA et al. High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response? 2008 Br J Radiol pmid:18559903
Luo B et al. Neuroradiological findings of intracranial schwannomas not arising from the stems of cranial nerves. 2004 Br J Radiol pmid:15569643
Chong S et al. Herpes simplex virus pneumonia: high-resolution CT findings. 2010 Br J Radiol pmid:20442279
Longo UG et al. Characteristics at haematoxylin and eosin staining of ruptures of the long head of the biceps tendon. 2009 Br J Sports Med pmid:18070808
Cahill RA et al. Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. 2004 Br J Surg pmid:15505871
Noguchi M Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. 2002 Br J Surg pmid:12445058
Arai K et al. Clinicopathological analysis of early gastric cancer with solitary lymph node metastasis. 2002 Br J Surg pmid:12390388
Salem AA et al. Evaluation of axillary lymph nodes using touch imprint cytology and immunohistochemistry. 2002 Br J Surg pmid:12390378
Smidt ML et al. Intraoperative scrape cytology of the sentinel lymph node in patients with breast cancer. 2002 Br J Surg pmid:12296899
Mizuno T et al. Clinical significance of immunohistochemically detectable lymph node metastasis in adenocarcinoma of the ampulla of Vater. 2006 Br J Surg pmid:16363020
Motomura K et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. 2002 Br J Surg pmid:12153631
Osugi H et al. Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. 2002 Br J Surg pmid:12081742
Braat AE et al. Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable. 2005 Br J Surg pmid:16231281
Noguchi M Sentinel lymph node biopsy and breast cancer. 2002 Br J Surg pmid:11851659
Rusby JE et al. Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. 2008 Br J Surg pmid:18844271
van Wely BJ et al. False-negative sentinel lymph node biopsy. 2008 Br J Surg pmid:18844270
Crombie N et al. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma. 2001 Br J Surg pmid:11578285
Shrikhande SV et al. Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis. 2003 Br J Surg pmid:14648737
Dhar DK et al. Prognostic significance of metastatic lymph node size in patients with gastric cancer. 2003 Br J Surg pmid:14648731
Wijeyaratne SM et al. Differences in the detection of cyclo-oxygenase 1 and 2 proteins in symptomatic and asymptomatic carotid plaques. 2001 Br J Surg pmid:11442526
Mofidi R et al. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. 2001 Br J Surg pmid:11442525
Nos C et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. 2003 Br J Surg pmid:14598414
Gruber G et al. Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy. 2005 Br. J. Cancer pmid:15597101
Srivastava S et al. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression. 2010 Br. J. Cancer pmid:19953094
Zhang GY et al. Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. 2005 Br. J. Cancer pmid:15583697
Barshack I et al. Spectral morphometric characterization of breast carcinoma cells. 1999 Br. J. Cancer pmid:10188915
Aaltonen K et al. Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. 2006 Br. J. Cancer pmid:16670718
Ouyang N et al. Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cells. 2010 Br. J. Cancer pmid:20531417
Cham KK et al. Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. 2010 Br. J. Cancer pmid:20531411
Chinje EC et al. 17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response. 2002 Br. J. Cancer pmid:11857025
Murayama T et al. Relation between outcomes and localisation of p-mTOR expression in gastric cancer. 2009 Br. J. Cancer pmid:19223902
Smith SL et al. S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. 2004 Br. J. Cancer pmid:15467767
Miyoshi N et al. Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis. 2009 Br. J. Cancer pmid:19904274
Faneyte IF et al. Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome. 2003 Br. J. Cancer pmid:12569384
Iijima H et al. Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma. 2004 Br. J. Cancer pmid:15292942
Suzuoki M et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. 2002 Br. J. Cancer pmid:12402154
Dudderidge TJ et al. Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer. 2007 Br. J. Cancer pmid:17406359
Fritzsche F et al. Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status. 2006 Br. J. Cancer pmid:16434994
Ino K et al. Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. 2006 Br. J. Cancer pmid:16434990
Kaneko K et al. Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growth. 2004 Br. J. Cancer pmid:15213719
Phatak P et al. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. 2007 Br. J. Cancer pmid:17406367
Andachi H et al. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma. 2002 Br. J. Cancer pmid:12177781
Salazar-Onfray F et al. Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. 2002 Br. J. Cancer pmid:12177778
Fan Y et al. Nucleostemin mRNA is expressed in both normal and malignant renal tissues. 2006 Br. J. Cancer pmid:16670719
Ceelen W et al. Recombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels. 2007 Br. J. Cancer pmid:17299396
Aubele M et al. PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas. 2007 Br. J. Cancer pmid:17299391
Kabuubi P et al. No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix. 2006 Br. J. Cancer pmid:16317434
Foster CS et al. Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. 2009 Br. J. Cancer pmid:19707199
Rennel ES et al. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. 2009 Br. J. Cancer pmid:19707198
Gibcus JH et al. Cortactin expression predicts poor survival in laryngeal carcinoma. 2008 Br. J. Cancer pmid:18268491
Nakayama N et al. KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. 2008 Br. J. Cancer pmid:19018267
Koike C et al. Solid stress facilitates spheroid formation: potential involvement of hyaluronan. 2002 Br. J. Cancer pmid:11953828
Ito Y et al. Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. 2002 Br. J. Cancer pmid:11953823
Teo NB et al. Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. 2002 Br. J. Cancer pmid:11953822
Miyazaki T et al. An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma. 2004 Br. J. Cancer pmid:15467768
Koelink PJ et al. Clinical significance of stromal apoptosis in colorectal cancer. 2009 Br. J. Cancer pmid:19654576
Bauer J et al. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. 2009 Br. J. Cancer pmid:19654573
Jiao W et al. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. 2002 Br. J. Cancer pmid:11857019
Di Benedetto M et al. Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative. 2003 Br. J. Cancer pmid:12799647
Hasuo T et al. Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer. 2007 Br. J. Cancer pmid:17179982
Dudek AZ et al. Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. 2007 Br. J. Cancer pmid:17653078
Jhavar S et al. Construction of tissue microarrays from prostate needle biopsy specimens. 2005 Br. J. Cancer pmid:16091762
Dredge K et al. Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. 2002 Br. J. Cancer pmid:12402158
Borle F et al. Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model. 2003 Br. J. Cancer pmid:14676813
Cen L et al. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound. 2007 Br. J. Cancer pmid:17848913
Escaff S et al. Study of matrix metalloproteinases and their inhibitors in prostate cancer. 2010 Br. J. Cancer pmid:20160732
Stoeltzing O et al. Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. 2002 Br. J. Cancer pmid:12402160
Myers E et al. A positive role for PEA3 in HER2-mediated breast tumour progression. 2006 Br. J. Cancer pmid:17060941
Yuen HF et al. Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. 2007 Br. J. Cancer pmid:18000500
Nagourney RA et al. Ex vivo analysis of topotecan: advancing the application of laboratory-based clinical therapeutics. 2003 Br. J. Cancer pmid:14583785
Inokuchi M et al. Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. 2003 Br. J. Cancer pmid:14583780
Cooper R et al. Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma? 2003 Br. J. Cancer pmid:12942120
Gray-Schopfer VC et al. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? 2006 Br. J. Cancer pmid:16880792
Epping MT et al. PRAME expression and clinical outcome of breast cancer. 2008 Br. J. Cancer pmid:18648365
Akil N et al. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. 2008 Br. J. Cancer pmid:18648363
Cellai I et al. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells. 2006 Br. J. Cancer pmid:16969347
Tischkowitz M et al. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness. 2006 Br. J. Cancer pmid:16786041